Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress

Fate Therapeutics (FATE) Misses Q2 EPS by 5c

August 4, 2021 5:19 PM EDT

Fate Therapeutics (NASDAQ: FATE) reported Q2 EPS of ($0.58), $0.05 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $6.31 million.

We are very pleased with the early clinical safety and activity we have observed with our... More